Developed by Klinikos; Roy Fraser (2012) Investigator Study File www.klinikos.com www.linkedin.com/company/klinikos-ltd.

Slides:



Advertisements
Similar presentations
CMRSC Division of Hematology/Oncology
Advertisements

1 US Investigator Meeting DIAS-4, Chicago, July 2011 Good Clinical Practice (GCP) for Investigators and the Research Team.
Essential Documentation GCP Training Seminar 12th October 2011
Timelines Trust informed June 2007
CROMS NIDCR Clinical Monitoring
Tips to a Successful Monitoring Visit
M ODULE F: P RE - STUDY A SSESSMENT V ISIT Denise Thwing 14 Apr Version: Final 14-Apr-2010.
The Principal Investigator’s Roles and Responsibilities Chicken Soup for the Busy Coordinator (May 2010)
HELP! The FDA is Coming! Margaret M. Groves, JD, CRA Director, Clinical Trials Quality Assurance (CTQA) School of Medicine (SOM) Compliance Office.
Content of Regulatory/Study Binder Human Subject Protection Office UConn Health Center Monika Haugstetter, MHA, RN, MSN & HSPO/IRB Staff.
Research Study Regulatory Binder Ronald Cowan, MD, PhD J. Gavin Lillevig, BS Summer Professional Didactics Data Management Psychiatric Neuroimaging Program.
Managing Regulatory Documents Electronically
Session III: (Breakout A) - Nuts and Bolts of Clinical Trials Participation for Investigators and Sub-Investigators Clinical Research Documentation.
Audit Ebru Mutlu-Omega CRO. General Purpose to help quality (to maintain quality at present) to assure quality (make sure that quality in future is maintained)
Regulatory Submission Process  Clinical Study Application: 1. Submit an appointment requestappointment request 2. Fill one of the three templates: - BE.
Monitoring and Auditing
GCP compliance for GenISIS  This presentation is intended for clinical staff involved in recruiting patients to the GenISIS (Genetics of Influenza Susceptibility.
Managing Sponsorship Research Services University of Oxford.
Neurological Emergencies Treatment Trials Network RAMPART This award is funded with support of NINDS, BARDA and the NIH CounterACT program.
Stanley Estime, MSCI December 9, 2014 Record Keeping: What is Regulatory Documentation and how should it be maintained? Tel:
Clinical Trial Infrastructure in Centres Lillian L. Siu Princess Margaret Hospital.
Coordinator University Clinical Research Pharmacy Investigational Drug Service (IDS) Marjorie Shaw Phillips, MS, RPh, FASHP Clinical Research Pharmacist.
Assessment of Interchangeable Multisource Medicines Quality of BE Data Dr. Henrike Potthast Training workshop: Assessment of Interchangeable.
Recapture of Day 1 Suchart Chongprasert, Ph.D. Food and Drug Administration “Practical Aspects in Performing Clinical and Bioanalytical Parts in BA/BE.
Good Clinical Practice (GCP)- An introduction Dr Noor Ibrahim Mohamed Sakian.
Research and Development Protocol Submission and Continuing Review Processes Kimberly Summers, PharmD Assistant Chief for Clinical Research South Texas.
Janet Ellen Holwell, CCRC, CCRA President, NY Metropolitan Chapter of ACRP.
Elements of Clinical Trial Quality Assurance Regulatory Coordinator –SCTR SUCCESS Center QA Monitor – NIDA Clinical Trials Network Stephanie Gentilin,
Role of the Oncology Research Team Carmen B. Jacobs, RN, OCN, CCRP.
Planning and Surviving An Audit/Monitoring visit Carmen B. Jacobs, BS, RN,OCN, CCRP U.T. MD Anderson Cancer Center Houston, Texas U.S.A.
MODULE I Close-Out Visit/Monitoring Reports Jane Fendl April 24, Versions: Final 24-Apr-2010.
RESCUE: ACRIN 4701 Protocol Development & Regulatory Compliance (PDRC) Josephine Schloesser, ACRIN Monitor Chris Steward, ACRIN QC Auditor.
Joint Research & Enterprise Office Training The team, the procedures, the monitor and the Sponsor Lucy H H Parker Clinical Research Governance Manager.
Role of the Oncology Research Team Carmen B. Jacobs, BS, RN,OCN, CCRP U.T.M.D. Anderson Cancer Center Houston, Texas U.S.A.
Monitoring IRB Monitoring of Clinical Trials. Types of Monitoring Internally Internally Externally Externally.
CLINICAL TRIALS – PHASE III. What are phase III trials  Confirmatory phase (Therapeutic confirmatory trial)  Trials are done to obtain sufficient evidence.
Read the SMALL PRINT of the 1572 The Essential GCP Document.
Quality of Bioequivalence Data Alfredo García - Arieta Training workshop: Training of BE assessors, Kiev, October 2009.
Essential Documents and Regulatory Files Lack of planning can constitute an emergency Rachel Sheppard Regulatory Director, OCRSS.
Arthi Ramakrishnan SHINE Site Manager Stroke Hyperglycemia Insulin Network Effort (SHINE) Stroke Hyperglycemia Insulin Network Effort (SHINE) Regulatory.
Study Closure Process Entropy is not a method Rachel Sheppard Regulatory Director, OCRSS.
Bundesinstitut für Arzneimittel und Medizinprodukte Pt WHO-consultant 1 WHO Training Workshop on Pharmaceutical Quality, Good Manufacturing Practice &
Agenda Introduction Study Objectives Study Design Delegation
Stanley Estime, MSCI October 19, 2015 Record Keeping: What is Regulatory Documentation and how should it be maintained? Tel:
RIHES-II: H ANDLING A UDITS AND I NSPECTIONS E FFECTIVE D ATE 25 D ECEMBER 2006 V ERSION : 3.0 บุญเหลือ พรึงลำภู 15 มกราคม 2557.
Sponsor Visits and Monitoring
CONDUCTING COMPLIANCE ASSESSMENTS Allen Ditch Director Corporate Quality Bristol Myers Squibb Medical Research Summit March 6, 2003.
Lifespan GOOD CLINICAL PRACTICE Record Management GCP May 2005.
Research Documentation Betty Wilson, CIP, MS Senior Compliance Manager MU IRB Lori Wilcox, EdD Director of Academic Compliance, Corporate Compliance.
Session 2 IRB Training  What is the Principal Investigator’s role in Human Subject Research?  What is the role of the Investigator’s staff in Human Subject.
GCP (GOOD CLINICAL PRACTISE)
Site Set-up and Conduct Caroline O’Leary and Carrie Bayliss.
Slide 1 Standard Operating Procedures. Slide 2 Goal To review the standard operating procedures Creating the informed consent document Obtaining informed.
Responsibilities of Sponsor, Investigator and Monitor
Sponsor Visits and Monitoring Barbara Gallagher, RN Clinical Research Nurse Jefferson Clinical Research Institute.
HOW TO SCREEN PATIENTS AND BOOK THE BASELINE VISIT APPOINTMENT?
The Role and Responsibilities of the Clinical Research Coordinator
Responsibilities of Sponsor, Investigator and Monitor
CONDUCTING THE TRIAL AT
MAINTAINING THE INVESTIGATOR’S SITE FILE
Alyssa Speier, MS, CIP November 13, 2013
Reasons for Auditing There are many reasons for auditing. Some examples of these reasons might be: Requested by the IRB Committee Requested by an IRB.
Good Clinical Practice (GCP) requirements for ANODE
Regulatory Binder: Maintaining Essential Study Documentation
Elements of an Organized Regulatory Binder
Basics of Building and Understanding Data Collection Forms
Investigator of Record – Definition
CONDUCTING THE TRIAL AT
MAINTAINING THE INVESTIGATOR’S STUDY FILE
Good clinical practice
Presentation transcript:

Developed by Klinikos; Roy Fraser (2012) Investigator Study File

 CONTAINS ESSENTIAL DOCUMENTS THAT ALLOWS EVALUATION OF THE CONDUCT OF THE TRIAL  SERVES TO DOMONSTRATE COMPLIANCE WITH ICH-GCP Investigator study file purpose

Example Investigator study file contents 1. Contact Sheet 2. Log of Monitoring Visits 3. Patient Enrolment 4. Correspondence 5. Adverse Events 6. Trial Products 7. Randomisation 8. Laboratories 9. Protocol 10. Ethics 11. Trial Approval 12. Agreements & Finance 13. Trial Personnel & Training 14. Investigator Brochure 15. Signed Consent Forms 16. Source Documents 17. Data Queries & Resolutions 18. Final Report 19. Completed CRFs

 List all trial personnel; with addresses, telephone, fax numbers and (laminated) Contact Sheet

 Check up to date.  Visit reports are filed ( If required) Log of monitoring visits

 Patient screening log.  Patient enrolment log.  Patient identification log Patient enrolment

 All communication between primary investigator & sponsor/funder:  Documents from primary investigator  s  Chronological order Correspondence

 Copy of Adverse Event/Serious Adverse Events Forms.  Copy of communication with Regulatory Authority Adverse events

 Copy of Labelling details.  Receipt of I.M.P.  Copy of dispensing information.  I.M.P. dispensing/returns record Trial products (pharmacy)

7. Randomisation  Copy of Randomisation Schedule.  Sealed Randomisation envelopes.  Code Breaks.  Code Breaks activation documentation.

 Name and address of clinical laboratory.  Laboratory accreditation certification.  Instructions.  Record of retained tissue, samples and location & I.D.  Normal ranges.  Patient Lab results Laboratories

 Signed Final Protocol (plus earlier versions).  Signed Amendments.  Sample CRF.  Final Patient Information Sheet (on headed paper).  Final Consent Form (on headed paper).  G.P. Letter (on headed paper)- if required Protocol

10. Ethics  Copy of name and address of Ethics Committee (E.C.)  Composition of Ethics Committee  Copy of application form  Copy of protocol reviewed by E.C.  Letter of approval (stating what has been approved)  Copy of updates on progression of trial by E.C.  Copy of notification of trial completion and report summary to E.C  Notification of adverse events to E.C.

 Copy of letter of regulatory approval form Competent Authority Trial Approval

12. Agreements and Finance  Financial Agreements.  Indemnity / Insurance.  Outsourcing agreements.  Confidentiality / Disclosure agreements.  Copy of archive arrangements.

13. Trial personnel and training  Signed & Dated C.V.’s of Study Team - (eg P.I., Research Nurses, Pharmacist)  Authorisation/delegation Log  Copy of Investigator GCP responsibilities  Copy of pre study and initiation visit reports  Copy of any special instructions  Evidence of staff training (Certificates, Inductions)

14. Investigator Brochure  Copy of current Investigator Brochure.  Copy of any ancillary trial product information.

15. Signed Consent Forms  Copy of blank consent form on letterhead plus any previous versions.  Actual patient signed Consent Forms

16. Source Documents  Any source data generated for the trial:  (Copies of X-ray reports, Endoscopy)

17. Data queries and resolutions  Copy of signed data queries.

18. Final Report  Copy of final report.

19. Completed case report forms  All copies of CRFs (if required in Site File).